|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.39 USD | +3.08% |
|
-4.22% | +29.87% |
| Mar. 15 | North American Morning Briefing : Inflation -2- | DJ |
| Mar. 14 | Wells Fargo Upgrades NeuroPace to Overweight From Equalweight, Raises Price Target to $20 From $16 | MT |
NeuroPace, Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was USD 65.42 million compared to USD 45.52 million a year ago. Net loss was USD 32.96 million compared to USD 47.08 million a year ago.
Basic loss per share from continuing operations was USD 1.27 compared to USD 1.91 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +29.87% | 385M | |
| +8.07% | 219B | |
| +6.59% | 183B | |
| +11.26% | 133B | |
| +26.57% | 108B | |
| +0.65% | 63.06B | |
| +13.35% | 52.02B | |
| -0.62% | 48.2B | |
| -0.93% | 40.37B | |
| +11.54% | 39.35B |
NEUROPACE, INC. 
